Neuronetics (STIM) Cash from Operations Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 44.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.68% |
| Dec 31, 2025 | 110.47% |
| Sep 30, 2025 | 85.23% |
| Jun 30, 2025 | 29.42% |
| Mar 31, 2025 | -41.43% |
| Dec 31, 2024 | -503.00% |
| Sep 30, 2024 | 46.49% |
| Jun 30, 2024 | 43.75% |
| Mar 31, 2024 | 21.02% |
| Dec 31, 2023 | 169.68% |
| Sep 30, 2023 | -55.59% |
| Jun 30, 2023 | 1.30% |
| Mar 31, 2023 | -24.88% |
| Dec 31, 2022 | 32.34% |
| Sep 30, 2022 | 23.62% |
| Jun 30, 2022 | -55.06% |
| Mar 31, 2022 | -32.88% |
| Dec 31, 2021 | -165.65% |
| Sep 30, 2021 | -139.57% |
| Jun 30, 2021 | 39.12% |
| Mar 31, 2021 | 32.84% |
| Dec 31, 2020 | 73.40% |
| Sep 30, 2020 | 53.58% |
| Jun 30, 2020 | -38.45% |
| Mar 31, 2020 | -42.63% |
| Dec 31, 2019 | -181.33% |
| Sep 30, 2019 | -55.77% |
| Jun 30, 2019 | -34.27% |
| Mar 31, 2019 | -15.34% |
| Dec 31, 2018 | -949.25% |
| Sep 30, 2018 | -154.69% |